Publikationen von Andreas Menke
Alle Typen
Zeitschriftenartikel (52)
2018
Zeitschriftenartikel
19, 61 (2018)
Correction to: Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling (vol 16, 266, 2015). GENOME BIOLOGY 2016
Zeitschriftenartikel
69, S. 161 - 171 (2016)
Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests. PSYCHONEUROENDOCRINOLOGY 2015
Zeitschriftenartikel
16, 266 (2015)
Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling. GENOME BIOLOGY
Zeitschriftenartikel
57, S. 1 - 13 (2015)
An analysis of gene expression in PTSD implicates genes involved in the glucocorticoid receptor pathway and neural responses to stress. PSYCHONEUROENDOCRINOLOGY
Zeitschriftenartikel
86 (5), S. 1189 - 1202 (2015)
Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders. NEURON 2014
Zeitschriftenartikel
44, S. 35 - 46 (2014)
Dexamethasone stimulated gene expression in peripheral blood indicates glucocorticoid-receptor hypersensitivity in job-related exhaustion. PSYCHONEUROENDOCRINOLOGY
Zeitschriftenartikel
83 (2), S. 344 - 360 (2014)
MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity. NEURON
Zeitschriftenartikel
16 (3), S. 395 - 404 (2014)
Epigenetic alterations in depression and antidepressant treatment. Dialogues in clinical neuroscience 2013
Zeitschriftenartikel
25 (5), S. 579 - 591 (2013)
Gene expression: Biomarker of antidepressant therapy? INTERNATIONAL REVIEW OF PSYCHIATRY
Zeitschriftenartikel
8 (6), e64947 (2013)
Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach. PLOS ONE 2012
Zeitschriftenartikel
18 (36), S. 5879 - 5889 (2012)
Epigenetics, Depression and Antidepressant Treatment. Current Pharmaceutical Design
Zeitschriftenartikel
37 (6), S. 1455 - 1464 (2012)
Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients. Neuropsychopharmacology
Zeitschriftenartikel
37 (4), S. 565 - 575 (2012)
Polymorphisms within the metabotropic glutamate receptor 1 gene are associated with depression phenotypes. Psychoneuroendocrinology
Zeitschriftenartikel
37 (3), S. 797 - 807 (2012)
Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation. Neuropsychopharmacology 2011
Zeitschriftenartikel
124 (4), S. 317 - 328 (2011)
Somatization in major depression - clinical features and genetic associations. Acta Psychiatrica Scandinavica
Zeitschriftenartikel
44 (6), S. 295 - 295 (2011)
BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry
Zeitschriftenartikel
68 (9), S. 901 - 910 (2011)
Using Polymorphisms in FKBP5 to Define Biologically Distinct Subtypes of Posttraumatic Stress Disorder Evidence From Endocrine and Gene Expression Studies. Archives of General Psychiatry
Zeitschriftenartikel
44 (6), S. 300 - 300 (2011)
Gender related differential response to dexamethasone in endocrine and immune measures in depressed patients and healthy controls. Pharmacopsychiatry
Zeitschriftenartikel
21 (Suppl. 3), S. S248 - S249 (2011)
Glucocorticoid induced FKBP5-gene expression in depressed patients and healthy controls. European Neuropsychopharmacology
Zeitschriftenartikel
44 (6), S. 308 - 308 (2011)
Effectiveness of a standardized cognitive training in depression and the interaction with HPA-axis regulation. Pharmacopsychiatry